Cefotaxime Taxim 1gm Injection - Cefotax ₹ 99 / Piece Get Latest Price Product Brochure Strength 1000 mg Pack Type Vial Brand Name Taxim Manufacturer Alkem Laboratories Ltd Usage To treat bacterial infections Available strength's 250mg 500mg 1000mg Product Name: Taxim 1gm InjectionBrand Name: Taxim, Cefotax, ClaforanComposition: Cefotaxime (1gm)Manufacturer/Marketer: Alkem Laboratories LtdPackaging: To be provided (specify packaging details if available)Treatment: Bacterial infections (including respiratory, urinary tract, skin, and soft tissue infections)Product Description: Taxim 1gm Injection contains Cefotaxime, a third-generation cephalosporin antibiotic. It is used to treat a variety of bacterial infections by inhibiting bacterial cell wall synthesis. Cefotaxime is effective against a wide range of pathogens, including those resistant to other antibiotics. It is commonly used for severe infections such as pneumonia, meningitis, and septicemia.Let me know if you need more information or adjustments

Doxypen Doxycycline 100mg Capsule ₹ 28 / Stripe Get Latest Price Product Brochure Strength 100mg Packaging Size 1x10 Packaging Type Stripe Brand Doxypen Shelf Life 24 Months Prescription/Non Prescription Prescription Country of Origin Made in India Doxypen-100 Capsule 10's treats urinary tract infections, intestinal infections, respiratory infections, eye infections, sexually transmitted infections (like gonorrhoea, syphilis), gum infections, diseases (like periodontitis), and others.

Genticyn Gentamicin 80mg Injection - Garamycin ₹ 55 / Vial Get Latest Price Product Brochure Strength 80 mg Packaging Size 2 ml Brand Name Genticyn Manufacturer Abbott Injection Site IV or IM Composition Gentamicin 80mg Packaging Type Box Usage / Application Personal Product Name: Genticyn 80mg Injection Brand Name: Genticyn, Garamycin, Amikacin Composition: Gentamicin (80mg) Manufacturer/Marketer: Abbott Packaging: To be provided (specify packaging details if available) Treatment: Bacterial infections, respiratory infections, urinary tract infections Product Description: Genticyn 80mg Injection contains Gentamicin, an antibiotic used to treat serious bacterial infections. It works by inhibiting bacterial protein synthesis, effectively killing or stopping the growth of bacteria. It is commonly used for treating infections in the respiratory tract, urinary tract, and bloodstream, among others

LQUIN 250MG 10 TAB LEVOFLOXACIN ₹ 46 / Stripe Get Latest Price Product Brochure Strength 250 mg Packaging Type Strip Packaging Size 10*10 Tablets Quantity Unit Strips Brand LQUIN 250MG Usage / Application Personal Minimum order quantity: 10 Stripe Product Name: Lquin 250mg/500mg Tablet Brand Name: Lquin, Levaquin, Tavanic Composition: Levofloxacin (250mg/500mg) Manufacturer/Marketer: Cipla Ltd Packaging: To be provided (specify packaging details if available) Treatment: Bacterial infections (e.g., respiratory tract infections, urinary tract infections, skin infections, and more) Product Description: Lquin Tablet contains Levofloxacin, a broad-spectrum antibiotic belonging to the fluoroquinolone class. It works by inhibiting bacterial DNA replication, thereby preventing the growth of bacteria. Commonly used to treat a variety of bacterial infections, including respiratory, urinary, and skin infections

Augmentin Dds Syrup ₹ 179 / Box Get Latest Price Product Brochure Strength 625 mg Brand Name Augmentin Manufacturer Glaxo SmithKline Pharmaceuticals Ltd. Form Oral Suspension Packaging type Box Composition CO AMOXYCLAV Country of Origin Made in India Minimum order quantity: 100 Box Augmentin DDS Syrup 30 ml belongs to a group of antibiotics known as penicillin antibiotics. It is generally prescribed to prevent middle ear and sinus infections, throat or lung respiratory tract infections, urinary tract infections, skin infections, soft tissue infections, dental infections, and joint and bone infections. Augmentin DDS Syrup 30 ml consists of two medicines: Amoxycillin and Clavulanic acid. Amoxycillin acts by destroying the outer protein layer, thereby killing the bacteria (bactericidal action). Clavulanic acid inhibits the enzyme beta-lactamase, which prevents bacteria from destroying the efficacy of amoxycillin. As a result, the action of Clavulanic acid allows Amoxycillin to work better and kill the bacteria. Augmentin DDS Syrup 30 ml does not work against infections caused by viruses, including colds and flu. The dose of Augmentin DDS Syrup 30 ml can vary depending on your condition and the severity of the infection. Also, it is recommended to complete the course of medicine even if you feel better as it is an antibiotic, and leaving it in between may lead to even severe infection that will, in fact, stop responding to the antibiotic as well (antibiotic resistance). The common side effects of Augmentin DDS Syrup 30 ml include vomiting, nausea, and diarrhoea. Everyone may not experience the above side effects. In case of any discomfort, speak with a doctor. Before starting Augmentin DDS Syrup 30 ml, please inform your doctor if you have any allergy (against any antibiotic) or kidney or liver problems. Do not take Augmentin DDS Syrup 30 ml on your own as self-medication since it may lead to antibiotic resistance in which antibiotics fail to act against specific bacterial infections. Augmentin DDS Syrup 30 ml is safe for children if prescribed by a doctor; the dose and duration may vary depending on the child’s weight and the severity of the infection. Inform your doctor about all the medicines you are taking and about your health condition to rule out any unpleasant side effects.

Uses and Benefits: INTACEF-3 INJ is used for treating various infections including respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, and infections of the heart lining and valves.

Marbomet tablets contain the most advanced fluoroquinolone marbofloxacin.It is a broad-spectrum bactericidal antibiotic inhibiting bacterial DNA-gyrase. Fluoroquinolones are effective against beta-lactamase-producing bacteria. Composition: MARBOFLOXACIN Class: Fluoroquinolone Antibiotic Indications/Uses Urinary tract infections Respiratory tract infections Soft-tissue infections Skin infections

ivermectin for humans 12mg Tablet ₹ 50 / Stripe Get Latest Price Strength 12mg Packaging Type Strip Prescription Required Yes Composition (Salts) Ivermectin Usages Covid 19 Although vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), have been developed and distributed, major challenges remain regarding vaccine production and allocation.1 The identification of inexpensive, widely available, and effective therapies against Covid-19 is of great importance. The repurposing of existing medicines that are widely available and that have reasonably well understood safety profiles has appeal.2 One drug that has received considerable public use and interest is ivermectin, which is typically used as an antiparasitic drug. Ivermectin inhibits the chloride channels of helminthic parasites and has been shown to have clinical efficacy for the treatment of onchocerciasis, strongyloidiasis, and ectoparasitic infection (e.g., scabies).3 The in vitro antiviral activity of ivermectin has been explored against a spectrum of viruses, including severe acute respiratory syndrome coronavirus 1, human immunodeficiency virus, dengue virus, Zika virus, yellow fever virus, West Nile virus, Hendra virus, chikungunya virus, Semliki Forest virus, Sindbis virus, and avian influenza virus.4 More than 60 randomized trials of ivermectin for the treatment of Covid-19 have been registered, and findings have been reported for as many as 31 clinical trials.5 The results have been discordant, and various review groups interpret the evidence differently — some advocating for benefits of ivermectin, and others reticent to conclude a benefit.6-8 However, most trials have been small, and several have been withdrawn from publication owing to concerns about credibility.9 To evaluate the efficacy of ivermectin for the prevention of progression of Covid-19 resulting in hospitalization among outpatients with SARS-CoV-2 infection, we conducted a randomized, placebo-controlled, adaptive platform trial (TOGETHER) in the state of Minas Gerais, Brazil. Although various interventions were assessed in this trial, we report here on the use of ivermectin at a dose of 400 μg per kilogram of body weight for 3 days as compared with placebo.

iveremectin Ivecop 6 Mg Tablet ₹ 35 / Stripe Get Latest Price Strength 6mg Packaging Type Strip Prescription Required Yes Composition (Salts) Ivermectin Usages Covid 19 Although vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), have been developed and distributed, major challenges remain regarding vaccine production and allocation.1 The identification of inexpensive, widely available, and effective therapies against Covid-19 is of great importance. The repurposing of existing medicines that are widely available and that have reasonably well understood safety profiles has appeal.2 One drug that has received considerable public use and interest is ivermectin, which is typically used as an antiparasitic drug. Ivermectin inhibits the chloride channels of helminthic parasites and has been shown to have clinical efficacy for the treatment of onchocerciasis, strongyloidiasis, and ectoparasitic infection (e.g., scabies).3 The in vitro antiviral activity of ivermectin has been explored against a spectrum of viruses, including severe acute respiratory syndrome coronavirus 1, human immunodeficiency virus, dengue virus, Zika virus, yellow fever virus, West Nile virus, Hendra virus, chikungunya virus, Semliki Forest virus, Sindbis virus, and avian influenza virus.4 More than 60 randomized trials of ivermectin for the treatment of Covid-19 have been registered, and findings have been reported for as many as 31 clinical trials.5 The results have been discordant, and various review groups interpret the evidence differently — some advocating for benefits of ivermectin, and others reticent to conclude a benefit.6-8 However, most trials have been small, and several have been withdrawn from publication owing to concerns about credibility.9 To evaluate the efficacy of ivermectin for the prevention of progression of Covid-19 resulting in hospitalization among outpatients with SARS-CoV-2 infection, we conducted a randomized, placebo-controlled, adaptive platform trial (TOGETHER) in the state of Minas Gerais, Brazil. Although various interventions were assessed in this trial, we report here on the use of ivermectin at a dose of 400 μg per kilogram of body weight for 3 days as compared with placebo.